GeneProt

GeneProt was a pioneering proteomics company that established the world's first industrial-scale protein analysis facility. The company focused on the discovery of novel therapeutic proteins and biomarkers by analyzing the proteome of human plasma and other biological samples. Utilizing high-performance computing and mass spectrometry, GeneProt aimed to bridge the gap between genomics and drug development. The company's business model centered on large-scale collaborations, most notably a significant multi-year partnership with Novartis to identify drug targets. Despite its advanced technological infrastructure and significant venture backing, GeneProt faced financial challenges and high operational costs, leading to its liquidation in the mid-2000s.